BRPI0408601A - compostos com ação nootrópica, sua preparação, composições farmacêuticas os contendo, e seu uso - Google Patents
compostos com ação nootrópica, sua preparação, composições farmacêuticas os contendo, e seu usoInfo
- Publication number
- BRPI0408601A BRPI0408601A BRPI0408601-5A BRPI0408601A BRPI0408601A BR PI0408601 A BRPI0408601 A BR PI0408601A BR PI0408601 A BRPI0408601 A BR PI0408601A BR PI0408601 A BRPI0408601 A BR PI0408601A
- Authority
- BR
- Brazil
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- action
- nootropic
- Prior art date
Links
- 230000001777 nootropic effect Effects 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 208000028698 Cognitive impairment Diseases 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 230000003070 anti-hyperalgesia Effects 0.000 abstract 1
- 125000002619 bicyclic group Chemical group 0.000 abstract 1
- 230000003925 brain function Effects 0.000 abstract 1
- 208000010877 cognitive disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000000638 stimulation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000573A ITMI20030573A1 (it) | 2003-03-24 | 2003-03-24 | Composti ad azione nootropica, loro preparazione, |
PCT/EP2004/050339 WO2004085438A2 (en) | 2003-03-24 | 2004-03-22 | Pyrroloimidazole derivatives, their preparation, pharmaceutical composition containing them, and their use as nootropic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0408601A true BRPI0408601A (pt) | 2006-03-07 |
Family
ID=33042696
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0408601-5A BRPI0408601A (pt) | 2003-03-24 | 2004-03-22 | compostos com ação nootrópica, sua preparação, composições farmacêuticas os contendo, e seu uso |
Country Status (23)
Country | Link |
---|---|
US (3) | US7544705B2 (pt) |
EP (1) | EP1608655B8 (pt) |
JP (1) | JP4920408B2 (pt) |
CN (1) | CN100522963C (pt) |
AT (1) | ATE401327T1 (pt) |
AU (1) | AU2004224087B2 (pt) |
BR (1) | BRPI0408601A (pt) |
CA (1) | CA2520008C (pt) |
CY (1) | CY1108401T1 (pt) |
DE (1) | DE602004015089D1 (pt) |
DK (1) | DK1608655T3 (pt) |
EA (1) | EA009558B1 (pt) |
ES (1) | ES2309534T3 (pt) |
HR (1) | HRP20050833A2 (pt) |
IT (1) | ITMI20030573A1 (pt) |
NO (1) | NO20054898L (pt) |
NZ (1) | NZ543154A (pt) |
PL (2) | PL1608655T3 (pt) |
PT (1) | PT1608655E (pt) |
RS (1) | RS20050725A (pt) |
SI (1) | SI1608655T1 (pt) |
WO (1) | WO2004085438A2 (pt) |
ZA (1) | ZA200508578B (pt) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI20030573A1 (it) * | 2003-03-24 | 2004-09-25 | Nikem Research Srl | Composti ad azione nootropica, loro preparazione, |
EP1925304A1 (en) * | 2006-11-15 | 2008-05-28 | Nikem Research S.R.L. | Pyrrolo[1,2-a]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents |
ITMI20070770A1 (it) | 2007-04-16 | 2008-10-17 | Brane Discovery S R L | Impiego di dimiracetam nel trattamento del dolore cronico |
AU2012201853B2 (en) * | 2007-04-16 | 2013-06-27 | Neurotune Ag | Use of dimiracetam in the treatment of chronic pain |
ES2637497T3 (es) | 2008-10-16 | 2017-10-13 | The Johns Hopkins University | Procedimientos y composiciones para la mejora de la función cognitiva |
US9125898B2 (en) | 2008-11-14 | 2015-09-08 | Neurotune Ag | Acetam derivatives for pain relief |
CA2789014C (en) * | 2010-02-09 | 2019-01-15 | Michela Gallagher | Methods and compositions for improving cognitive function |
PL2598504T3 (pl) * | 2010-07-26 | 2014-10-31 | Neurotune Ag | Sposób otrzymywania dimiracetamu |
EP3610890A1 (en) | 2012-11-14 | 2020-02-19 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
JP6433482B2 (ja) | 2013-03-15 | 2018-12-05 | エージンバイオ, インコーポレイテッド | 認知機能を改善するための方法および組成物 |
US10806717B2 (en) | 2013-03-15 | 2020-10-20 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
JP6899043B2 (ja) | 2015-05-22 | 2021-07-07 | エージンバイオ, インコーポレイテッド | レベチラセタムの持続放出性医薬組成物 |
JOP20190251A1 (ar) | 2017-05-31 | 2019-10-21 | Metys Pharmaceuticals AG | تركيبات تآزرية تشتمل على (r)-ديميراسيتام (1) و(s)-ديميراسيتام (2) بنسبة غير راسيمية |
US20220047548A1 (en) | 2018-12-04 | 2022-02-17 | Metys Pharmaceuticals AG | SYNERGISTIC COMPOSITIONS COMPRISING (R)-2-(2-OXOPYRROLIDIN-1-YL)BUTANAMIDE AND (S)-2-(2-e OXOPYRROLEDIN-1-YL)BUTANAMEDE IN A NON-RACEMIC RATIO |
CN113195494B (zh) | 2018-12-04 | 2024-06-28 | 美蒂斯制药公司 | 包含非外消旋比例的R-2-(取代的磺酰基)-六氢-吡咯并[1,2-a]吡嗪-6(2H)-酮和S-2-(取代的磺酰基)-六氢-吡咯并[1,2- a]吡嗪-6(2H)-酮的协同组合物 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4582838A (en) * | 1984-08-24 | 1986-04-15 | Warner-Lambert Company | Derivatives of dihydro-1H-pyrrolo[1,2-c]imidazol-3,5-dione as cognition activators |
US5200406A (en) * | 1988-02-08 | 1993-04-06 | I.S.F. Societa Per Azioni | Pharmaceutically useful 2,5-dioxo-1H-octahydroimidazo[1,2-A]azepines |
IT1233860B (it) * | 1988-02-08 | 1992-04-21 | Isf Spa | Derivati del peridroazacicloalca (1,2-a) imidazolo ad attivita' nootropa |
JP3400466B2 (ja) * | 1991-10-28 | 2003-04-28 | 日本水産株式会社 | 高純度エイコサペンタエン酸またはそのエステルの製造方法 |
GB9123641D0 (en) * | 1991-11-07 | 1992-01-02 | Isf Spa | Process |
ITMI20030573A1 (it) * | 2003-03-24 | 2004-09-25 | Nikem Research Srl | Composti ad azione nootropica, loro preparazione, |
EP1925304A1 (en) * | 2006-11-15 | 2008-05-28 | Nikem Research S.R.L. | Pyrrolo[1,2-a]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents |
-
2003
- 2003-03-24 IT IT000573A patent/ITMI20030573A1/it unknown
-
2004
- 2004-03-22 RS YUP-2005/0725A patent/RS20050725A/sr unknown
- 2004-03-22 ES ES04741432T patent/ES2309534T3/es not_active Expired - Lifetime
- 2004-03-22 US US10/550,483 patent/US7544705B2/en not_active Expired - Fee Related
- 2004-03-22 CA CA2520008A patent/CA2520008C/en not_active Expired - Fee Related
- 2004-03-22 PL PL04741432T patent/PL1608655T3/pl unknown
- 2004-03-22 JP JP2006505479A patent/JP4920408B2/ja not_active Expired - Fee Related
- 2004-03-22 SI SI200430868T patent/SI1608655T1/sl unknown
- 2004-03-22 BR BRPI0408601-5A patent/BRPI0408601A/pt not_active Application Discontinuation
- 2004-03-22 EP EP04741432A patent/EP1608655B8/en not_active Expired - Lifetime
- 2004-03-22 PT PT04741432T patent/PT1608655E/pt unknown
- 2004-03-22 PL PL378939A patent/PL378939A1/pl unknown
- 2004-03-22 WO PCT/EP2004/050339 patent/WO2004085438A2/en active IP Right Grant
- 2004-03-22 DK DK04741432T patent/DK1608655T3/da active
- 2004-03-22 AT AT04741432T patent/ATE401327T1/de not_active IP Right Cessation
- 2004-03-22 AU AU2004224087A patent/AU2004224087B2/en not_active Ceased
- 2004-03-22 EA EA200501501A patent/EA009558B1/ru not_active IP Right Cessation
- 2004-03-22 NZ NZ543154A patent/NZ543154A/en unknown
- 2004-03-22 DE DE602004015089T patent/DE602004015089D1/de not_active Expired - Lifetime
- 2004-03-22 CN CNB2004800055916A patent/CN100522963C/zh not_active Expired - Fee Related
- 2004-03-22 HR HR20050833A patent/HRP20050833A2/hr not_active Application Discontinuation
-
2005
- 2005-10-21 ZA ZA200508578A patent/ZA200508578B/en unknown
- 2005-10-24 NO NO20054898A patent/NO20054898L/no not_active Application Discontinuation
-
2008
- 2008-10-08 CY CY20081101113T patent/CY1108401T1/el unknown
-
2009
- 2009-02-13 US US12/378,475 patent/US7732473B2/en not_active Expired - Fee Related
-
2010
- 2010-02-17 US US12/658,973 patent/US20100173945A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0408601A (pt) | compostos com ação nootrópica, sua preparação, composições farmacêuticas os contendo, e seu uso | |
BR0309875A (pt) | métodos e composições para tratamento de distúrbios do sistema nervoso periférico e novos compostos úteis para isto | |
SE0101387D0 (sv) | Novel compounds | |
EA200501095A1 (ru) | Фенилацетамиды и их применение в качестве модуляторов глюкокиназы | |
BR0309544A (pt) | Preparação farmacêutica contendo oxicodona e naloxona | |
BRPI0918868B8 (pt) | compostos moduladores do receptor de nmda e composições compreendendo os mesmos | |
UY26130A1 (es) | Compuestos para tratar la obesidad | |
ECSP055609A (es) | "Uso de inhibidores de la IkB-quinasa para el tratamiento del dolor" | |
DE69507029D1 (de) | Pharmazeutische zusammensetzungen enthaltend einen opiat antagonist und calcium salze, ihre verwendung zur behandlung von endorphin-vermittelten krankheiten | |
PA8657201A1 (es) | Compuestos de 3h-oxazolo y 3h-tiazolo [4, 5-d] pirimidin-2-ona 3, 5-disustituida y 3, 5, 7 - trisustituida y profarmacos de los mismos | |
BRPI0418099A (pt) | compostos, composição farmacêutica, e uso de um composto | |
ES2190246T3 (es) | Nuevos compuestos de tiazolopirimidina. | |
EA200100154A1 (ru) | Бензоциклогептены, способ их получения, содержащие их фармацевтические препараты и их применение для получения лекарственных средств | |
CY1109361T1 (el) | Υποκατεστημενες 4-αμινοκυκλοεξανολες | |
CY1113116T1 (el) | Υποκατεστημενες 4-αμινοκυκλοεξανολες | |
DE69531098D1 (de) | Piperidine und pyrrolidine | |
DK0832081T3 (da) | Bicykliske-aromatiske forbindelser | |
SE9802208D0 (sv) | Novel compounds | |
EA200601846A1 (ru) | Содержащие бензоксазины лекарственные комбинации для лечения заболеваний дыхательных путей | |
ATE432068T1 (de) | Cetirizin und pseudoephedrin enthaltende tablette | |
EP1663201A4 (en) | USE OF NOVEL 2-OXO-HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | |
SE9802209D0 (sv) | Novel compounds | |
ATE296814T1 (de) | Ionenkanal modulierende mittel | |
BR0211223A (pt) | Derivados de 4-aminociclohexanol substituìdos | |
NO990322L (no) | Farmas°ytisk blanding inneholdende en 5HT2c-antagonist og en D2-antagonist |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B15K | Others concerning applications: alteration of classification |
Free format text: PARA INT.CL: C07D 487/04, A61K 31/4188, A61P 25/00 Ipc: C07D 487/04 (2011.01), A61K 31/4188 (2011.01) |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B25A | Requested transfer of rights approved |
Owner name: BRANE DISCOVERY S.R.L. IN LIQUIDAZIONE (IT) Free format text: TRANSFERIDO DE: NIKEM RESEARCH S.R.L. |
|
B25A | Requested transfer of rights approved |
Owner name: BRANE DISCOVERY S.R.L. IN LIQUIDAZIONE (IT) , NIKE Free format text: TRANSFERIDO DE: BRANE DISCOVERY S.R.L. IN LIQUIDAZIONE |
|
B25A | Requested transfer of rights approved |
Owner name: BRANE DISCOVERY S.R.L. IN LIQUIDAZIONE (IT) , NEUR Free format text: TRANSFERIDO DE: NIKEM RESEARCH S.R.L. |
|
B11E | Dismissal acc. art. 34 of ipl - requirements for examination incomplete | ||
B11M | Decision cancelled [chapter 11.13 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07F | Notification of approval that there is no relation to art. 229 of lpi (pipeline patents) [chapter 7.6 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |